Literature DB >> 15928276

Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.

Carl S Apstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15928276     DOI： 10.1001/jama.293.21.2596

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial).

Authors:  Harry P Selker; James E Udelson; Joseph M Massaro; Robin Ruthazer; Ralph B D'Agostino; John L Griffith; Patricia R Sheehan; Patrice Desvigne-Nickens; Yves Rosenberg; Xin Tian; Ellen M Vickery; James M Atkins; Tom P Aufderheide; Assaad J Sayah; Ronald G Pirrallo; Michael K Levy; Michael E Richards; Darren A Braude; Delanor D Doyle; Ralph J Frascone; Donald J Kosiak; James M Leaming; Carin M Van Gelder; Gert-Paul Walter; Marvin A Wayne; Robert H Woolard; Joni R Beshansky
Journal:  Am J Cardiol       Date:  2014-03-01       Impact factor: 2.778

2.  Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

Authors:  Harry P Selker; Joni R Beshansky; Patricia R Sheehan; Joseph M Massaro; John L Griffith; Ralph B D'Agostino; Robin Ruthazer; James M Atkins; Assaad J Sayah; Michael K Levy; Michael E Richards; Tom P Aufderheide; Darren A Braude; Ronald G Pirrallo; Delanor D Doyle; Ralph J Frascone; Donald J Kosiak; James M Leaming; Carin M Van Gelder; Gert-Paul Walter; Marvin A Wayne; Robert H Woolard; Lionel H Opie; Charles E Rackley; Carl S Apstein; James E Udelson
Journal:  JAMA       Date:  2012-03-27       Impact factor: 56.272

3.  High-dose glucose-insulin-potassium has hemodynamic benefits and can improve cardiac remodeling in acute myocardial infarction treated with primary percutaneous coronary intervention: From a randomized controlled study.

Authors:  Yanhui Li; Lin Zhang; Lei Zhang; Haiyong Zhang; Nianzhong Zhang; Zhongsu Yang; Mingming Gao; Xinchun Yang; Liang Cui
Journal:  J Cardiovasc Dis Res       Date:  2010-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.